← Open Payments lookup

TRACEE HARRIS: Open Payments

NPI 1376114959 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,268 in 164 payments from 20 companies in 2025. Trend: 2023 $2,870 · 2024 $2,725 · 2025 $3,268

Food & beverage: $3,239Education: $29
CompanyPaymentsAmount
ABBVIE INC.37$557
Otsuka America Pharmaceutical, Inc.23$411
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$366
E.R. Squibb & Sons, L.L.C.7$323
Lundbeck LLC14$322
Axsome Therapeutics, Inc.16$301
Corium, LLC10$225
LivaNova USA, Inc.4$114
Teva Pharmaceuticals USA, Inc.4$103
Almatica Pharma LLC5$87

Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, Auvelity, Azstarys, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, UZEDY.

Industry payments across TX — which companies pay providers there.